DaVita Aktie

DaVita für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 897914 / ISIN: US23918K1088

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
09.05.2022 12:02:00

DaVita Inc. to Participate in the Bank of America Securities 2022 Healthcare Conference

DENVER, May 9, 2022 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, will participate in a fireside chat with investors at the Bank of America Securities 2022 Healthcare Conference on Tuesday, May 10, 2022, at 11 a.m. EDT.

To view the live webcast, visit the Bank of America Securities page and create a free registration.  

About DaVita Inc.
DaVita (NYSE: DVA) is a comprehensive kidney care provider focused on transforming care to improve the quality of life for patients globally. The company is one of the largest providers of kidney care services in the U.S. and has been a leader in clinical quality and innovation for more than 20 years. DaVita is working to help increase equitable access to care for patients at every stage and setting along their kidney health journey—from slowing progression of kidney disease to streamlining the transplant process, from acute hospital care to dialysis at home. As of December 31, 2021, DaVita served 203,000 patients at 2,815 outpatient dialysis centers in the U.S. The company operated an additional 339 outpatient dialysis centers in ten countries worldwide. DaVita has reduced hospitalizations, improved mortality and worked collaboratively to propel the kidney care community to adopt an equitable, high-quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.

Contact:
Megan Anthony
Megan.Anthony@DaVita.com
636-675-6705

DaVita Logo (PRNewsfoto/DaVita)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/davita-inc-to-participate-in-the-bank-of-america-securities-2022-healthcare-conference-301542214.html

SOURCE DaVita Inc.

Analysen zu DaVita Inc Registered Shsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

DaVita Inc Registered Shs 141,40 0,64% DaVita Inc Registered Shs